We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume | Trades |
|---|---|---|---|---|---|---|
AYM | Australia United Mining Limited | 0.002 | 0.001 | 100.00% | 3,058,338 | 6 |
REEO | RareX Limited | 0.005 | 0.002 | 66.67% | 43,552 | 1 |
CT1 | Constellation Technologies Limited | 0.003 | 0.001 | 50.00% | 13,230,900 | 25 |
AOA | Ausmon Resources Limited | 0.0015 | 0.0005 | 50.00% | 4,150,000 | 6 |
HE8 | Helios Energy Ltd | 0.003 | 0.001 | 50.00% | 2,585,612 | 11 |
A8G | Australasian Metals Ltd | 0.13 | 0.04 | 44.44% | 79,796 | 9 |
OD6O | OD6 Metals Ltd | 0.055 | 0.015 | 37.50% | 172,208 | 5 |
IMUOF | Imugene Ltd | 0.019 | 0.005 | 35.71% | 475,932 | 8 |
X2MOA | X2M Connect Ltd | 0.002 | 0.0005 | 33.33% | 4,000,000 | 5 |
LMLO | Lincoln Minerals Limited | 0.004 | 0.001 | 33.33% | 150,000 | 1 |
IBXO | Imagion Biosystems Limited | 0.004 | 0.001 | 33.33% | 250,000 | 1 |
FreeCast, Inc. (NASDAQ: CAST), a technology company providing streaming media aggregation, distribution, and Platform-as-a-Service (PaaS) solutions, today announced it has entered into a reseller agreement for Starlink Business services. This agreement enables FreeCast to offer enterprise-grade satellite broadband connectivity alongside its growing portfolio of media, television, advertising, and digital engagement solutions.
SINGAPORE, June 18, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), an AI-native workforce management platform and integrated facility management (IFM) provider operating across Asia and beyond, today announced that its Board of Directors has resolved to effect a 30-for-1 reverse stock split of the Company's Class A ordinary shares. YY Group's Class A ordinary shares will begin trading on an adjusted basis giving effect to the reverse stock split, on June 23, 2026, under the existing ticker symbol "YYGH." The new CUSIP number of the Company's ordinary shares will be G9888Q129.
SARASOTA, Fla., June 16, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class, today announced that Kelvin Cooper, Ph.D., Chief Executive Officer and Senior Vice President of Research, will present at the Life Sciences Virtual Investor Forum on June 25, 2026.
The BIO International Convention Brings Together More Than 20,000 Biotech Industry Leaders From Around The WorldAUSTIN, Texas, June 17, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its team will be attending and participating at the BIO 2026 International Convention taking place June 22-25, 2026 in San Diego, California.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.